Marianne De Backer, PhD, is Vice President of Venture Investments at Johnson & Johnson Innovation – JJDC, Inc. (JJDC). She is based in California.
During her career at Johnson & Johnson, Marianne held roles in research, technology licensing and led a commercial business unit team to her most recent role in Janssen Business Development responsible for late-stage pharmaceutical deals. As a scientist and R&D group leader, Marianne was named as inventor on five patent applications. In her most recent role, Marianne was with Janssen Business Development leading the Infectious Diseases & Vaccines (IDV) TA and Emerging Markets (licensing, mergers & acquisition, and alliance management). Under her direct leadership over the past several years, the IDV pipeline grew significantly through creative partnerships.
Marianne holds an MBA from Erasmus University Rotterdam, a PhD in Biotechnology from the University of Ghent, a MSc in Molecular Biology from the University of Brussels, and an engineering degree in Biochemistry from the IH Ghent.